Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects

Journal of Bone and Mineral Research

Volumn 24, Issue 7, 2009, Pages 1263-1270

  Sjögren, Klara ^a   Lagerquist, Marie ^a   Moverare Skrtic, Sofia ^a   Andersson, Niklas ^a   Windahl, Sara H ^a   Swanson, Charlotte ^a   Mohan, Subburaman ^b   Poutanen, Matti ^c   Ohlsson, Claes ^a,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TURKU   (Finland)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone; CYP19A1; Estrogen; Hormone replacement therapy; Sex hormones

Indexed keywords

AROMATASE; ESTROGEN; MESSENGER RNA; OSTEOPROTEGERIN; PROCOLLAGEN; TESTOSTERONE;

ANIMAL EXPERIMENT; AROMATIZATION; ARTICLE; BONE DENSITY; BONE MASS; CONTROLLED STUDY; CORTICAL BONE; ESTROGEN ACTIVITY; FEMALE; GENE OVEREXPRESSION; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OVARIECTOMY; PROTEIN EXPRESSION; THICKNESS; TRABECULAR BONE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; AROMATASE; BONE DENSITY; COLLAGEN TYPE I; ESTRADIOL; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; OSTEOBLASTS; RATS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; TESTOSTERONE;

EID: 70349139687     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090208     Document Type: Article

References (43)

1. Orwoll ES 2003 Men, bone and estrogen: Unresolved issues. Osteoporos Int 14:93-98.
2. Riggs BL, Khosla S, Melton LJ III, 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302. (Pubitemid 34651948)
3. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C 2004 Androgens and bone. Endocr Rev 25:389-425.
4. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Lowik CW, Pols HA, van Leeuwen JP 1997 Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138: 5067-5070. (Pubitemid 27460951)
5. Nilsson LO, Boman A, Savendahl L, Grigelioniene G, Ohlsson C, Ritzen EM, Wroblewski J 1999 Demonstration of estrogen receptor-beta immunoreactivity in human growth plate cartilage. J Clin Endocrinol Metab 84:370-373. (Pubitemid 29036729)
6. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T 1997 Expression of estrogen receptor beta in rat bone. Endocrinology 138:4509-4512. (Pubitemid 27408505)
7. Vidal O, Kindblom LG, Ohlsson C 1999 Expression and localization of estrogen receptor-beta in murine and human bone. J Bone Miner Res 14:923-929. (Pubitemid 29262886)
8. Lindberg MK, Weihua Z, Andersson N, Moverare S, Gao H, Vidal O, Erlandsson M, Windahl S, Andersson G, Lubahn DB, Carlsten H, Dahlman-Wright K, Gustafsson JA, Ohlsson C 2002 Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. J Endocrinol 174:167-178. (Pubitemid 34965757)
9. Moverare S, Venken K, Eriksson AL, Andersson N, Skrtic S, Wergedal J, Mohan S, Salmon P, Bouillon R, Gustafsson JA, Vanderschueren D, Ohlsson C 2003 Differential effects on bone of estrogen receptor alpha and androgen receptor activation in orchidectomized adult male mice. Proc Natl Acad Sci USA 100:13573-13578. (Pubitemid 37448563)
10. Sims NA, Clement-Lacroix P, Minet D, Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M, Baron R 2003 A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest 111:1319-1327. (Pubitemid 36554702)
11. Tivesten A, Moverare-Skrtic S, Chagin A, Venken K, Salmon P, Vanderschueren D, Savendahl L, Holmang A, Ohlsson C 2004 Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats. J Bone Miner Res 19:1833-1839. (Pubitemid 41103435)
12. Bilezikian JP, Morishima A, Bell J, Grumbach MM 1998 Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339:599-603. (Pubitemid 28385657)
13. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698.
14. Oz OK, Hajibeigi A, Howard K, Cummins CL, van Abel M, Bindels RJ, Word RA, Kuro-o M, Pak CY, Zerwekh JE 2007 Aromatase deficiency causes altered expression of molecules critical for calcium reabsorption in the kidneys of female mice*. J Bone Miner Res 22:1893-1902. (Pubitemid 351229306)
15. Oz OK, Zerwekh JE, Fisher C, Graves K, Nanu L, Millsaps R, Simpson ER 2000 Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res 15:507-514. (Pubitemid 30134095)
16. Bouillon R, Bex M, Vanderschueren D, Boonen S 2004 Estrogens are essential for male pubertal periosteal bone expansion. J Clin Endocrinol Metab 89:6025-6029. (Pubitemid 39628410)
17. Rochira V, Zirilli L, Madeo B, Aranda C, Caffagni G, Fabre B, Montangero VE, Roldan EJ, Maffei L, Carani C 2007 Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: Evidences of a priming effect of estrogen for sex steroids action on bone. Bone 40:1662-1668. (Pubitemid 46779001)
18. Vanderschueren D, Venken K, Ophoff J, Bouillon R, Boonen S 2006 Clinical Review: Sex steroids and the periosteum-reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab 91:378-382. (Pubitemid 43236896)
19. Peng Z, Li X, Makela S, Vaananen HK, Poutanen M 2004 Skeletal changes in transgenic male mice expressing human cytochrome p450 aromatase. J Bone Miner Res 19:1320-1328. (Pubitemid 41094374)
20. Li X, Nokkala E, Yan W, Streng T, Saarinen N, Warri A, Huhtaniemi I, Santti R, Makela S, Poutanen M 2001 Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 142:2435-2442. (Pubitemid 32475760)
21. Li X, Strauss L, Kaatrasalo A, Mayerhofer A, Huhtaniemi I, Santti R, Makela S, Poutanen M 2006 Transgenic mice expressing p450 aromatase as a model for male infertility associated with chronic inflammation in the testis. Endocrinology 147:1271-1277. (Pubitemid 43244360)
22. Li X, Warri A, Makela S, Ahonen T, Streng T, Santti R, Poutanen M 2002 Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology 143:4074-4083. (Pubitemid 35251782)
23. Perkins LM, Payne AH 1988 Quantification of P450scc, P450(17) alpha, and iron sulfur protein reductase in Leydig cells and adrenals of inbred strains of mice. Endocrinology 123:2675-2682.
24. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:C113-C118.
25. Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M 2003 The human CYP19 (aromatase P450) gene: Update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 86:219-224. (Pubitemid 37412560)
26. Parakh TN, Hernandez JA, Grammer JC, Weck J, Hunzicker-Dunn M, Zeleznik AJ, Nilson JH 2006 Follicle-stimulating hormone/cAMP regulation of aromatase gene expression requires beta-catenin. Proc Natl Acad Sci USA 103:12435-12440. (Pubitemid 44267277)
27. Sasano H, Harada N 1998 Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev 19:593-607. (Pubitemid 28467713)
28. Shozu M, Simpson ER 1998 Aromatase expression of human osteoblast-like cells. Mol Cell Endocrinol 139:117-129. (Pubitemid 28340064)
29. Takayanagi R, Goto K, Suzuki S, Tanaka S, Shimoda S, Nawata H 2002 Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: Correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts. Mech Ageing Dev 123:1107-1114. (Pubitemid 34603094)
30. Wang L, Wang YD, Wang WJ, Li DJ 2009 Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice. Osteoporos Int 20:79-92.
31. Watanabe M, Noda M, Nakajin S 2007 Aromatase expression in a human osteoblastic cell line increases in response to prostaglandin E(2) in a dexamethasone-dependent fashion. Steroids 72:686-692. (Pubitemid 47126563)
32. Watanabe M, Simpson ER, Pathirage N, Nakajin S, Clyne CD 2004 Aromatase expression in the human fetal osteoblastic cell line SV-HFO. J Mol Endocrinol 32:533-545. (Pubitemid 38584654)
33. Dacquin R, Starbuck M, Schinke T, Karsenty G 2002 Mouse alphal(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn 224:245-251. (Pubitemid 34569065)
34. Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D 2002 Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 17:15-25. (Pubitemid 33150992)
35. Kalajzic Z, Liu P, Kalajzic I, Du Z, Braut A, Mina M, Canalis E, Rowe DW 2002 Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: Comparison between rat type I collagen and rat osteocalcin promoters. Bone 31:654-660. (Pubitemid 36092087)
36. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C 1999 Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 104:895-901. (Pubitemid 29536339)
37. Vidal O, Lindberg MK, Hollberg K, Baylink DJ, Andersson G, Lubahn DB, Mohan S, Gustafsson JA, Ohlsson C 2000 Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci USA 97:5474-5479. (Pubitemid 30313743)
38. Hildebrand T, Ruegsegger P 1997 Quantification of Bone Microarchitecture with the Structure Model Index. Comput Methods Biomech Biomed Engin 1:15-23.
39. Lindberg MK, Svensson J, Venken K, Chavoshi T, Andersson N, Moverare Skrtic S, Isaksson O, Vanderschueren D, Carlsten H, Ohlsson C 2006 Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss. Bone 38:85-92. (Pubitemid 43006078)
40. Waarsing JH, Day JS, Weinans H 2004 An improved segmentation method for in vivo microCT imaging. J Bone Miner Res 19:1640-1650. (Pubitemid 41094327)
41. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
42. Vidal O, Lindberg MK, Hollberg K, Baylink DJ, Andersson G, Lubahn DB, Mohan S, Gustafsson JA, Ohlsson C 2000 Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci USA 97:5474-5479. (Pubitemid 30313743)
43. Kearns AE, Khosla S, Kostenuik PJ 2008 Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29:155-192.